Module 1: CRRT Overview (Page Intentionally Blank) Module 1: CRRT Overview
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
KIDNEY FAILURE TREATMENT OPTIONS Choosing What’S Best for You What Kidneys Do
KIDNEY FAILURE TREATMENT OPTIONS Choosing What’s Best For You What Kidneys Do The kidneys are a pair of bean shaped organs located below your ribcage near the middle of your back. Kidneys play a vital role in the body by filtering blood, removing waste and extra water, balancing electrolytes—sodium, potassium, chloride, and biacarbonate, and regulating blood pressure. As kidneys filter blood they create urine/wastes which collect in the bladder until you go to the bath- room. If your body doesn’t remove these wastes, they build up in the blood and damage the body. For most people this damage occurs slowly over many years causing Chronic Kidney Disease (CKD). CKD eventually results in End Stage Renal Disease (ESRD) which is when dialysis or a transplant becomes necessary. 2 TREATMENT OPTIONS Treatment Options This guide will cover four treatment options for your condition: l Hemodialysis (in-center & home) l Peritoneal Dialysis l Kidney Transplantation l Comfort Care Introduction When diagnosed with kidney disease, the key to feeling better is to follow the treatment plan developed by your doctor and other members of your care team including nurses, dietitians, and social workers. Following the advice of your medical professionals will help you lead the healthiest lifestyle possible. When your kidneys are unable to remove extra fluid and waste from the body, dialysis is generally recommended. Dialysis helps alleviate many of the health problems people with kidney failure experience. Dialysis can be done in a hospital, a dialysis clinic, or at home. Once you know all of your treatment options, you will make the decision of where you choose to have dialysis with the help of your doctor, other health care professionals, and your family. -
Interaction Between Renal Replacement Therapy And
rren Cu t R y: es Romano, Surgery Curr Res 2014, 4:1 r e e a g r r c u h DOI: 10.4172/2161-1076.1000154 S Surgery: Current Research ISSN: 2161-1076 Review Article Open Access Interaction between Renal Replacement Therapy and Extracorporeal Membrane Oxygenation Support Thiago Gomes Romano* Assistant Teaching Professor for the Discipline of Nephrology, ABC Medical School Medical Intensivist at Hospital, Sírio-Libanês, Brazil Abstract Extracorporeal Membrane Oxygenation (ECMO) is one of the designations used for extracorporeal circuits capable of oxygenation, carbon dioxide removal and, eventually, circulatory support. Acute respiratory distress syndrome with severe hypoxemia or acidemia with high carbon dioxide levels in a scenario of low pulmonary tidal volume is its mainly indication. Acute Kidney Injury (AKI) and its complications such as volume overload and azotemia are common in this situation; some epidemiological studies have shown that around 78% of the patients demanding ECMO therapy develop AKI. Therefore, renal replacement therapy is required in about 50% of those cases. This papers aims to explain the concept of the ECMO circuit and the ways continuous renal replacement therapy (CRRT) can be instituted in critical ill patients who need ECMO. Keywords: ECMO; Renal replacement therapy; Dialysis internal jugular or femoral vein with the return placed in the femoral artery. Additionally, a jugular-carotid cannulation is one option despite Introduction the potential for neurological injury. In cases exclusively intended for Extracorporeal Membrane Oxygenation (ECMO) is one of the ventilatory support [venovenous (VV) ECMO], cannulation can be designations used for extracorporeal circuits capable of oxygenation, placed femoro-jugular, jugular-femoral or femoral-femoral depending carbon dioxide (CO ) removal and, eventually, circulatory support. -
Targeted High Volume Hemofiltration Could Avoid Extracorporeal Membrane Oxygenation in Some Patients with Severe Hantavirus Cardiopulmonary Syndrome
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 5 July 2020 doi:10.20944/preprints202007.0046.v1 Article Targeted High Volume Hemofiltration Could Avoid Extracorporeal Membrane Oxygenation in Some Patients with Severe Hantavirus Cardiopulmonary Syndrome René López1, 2, Rodrigo Pérez-Araos1, 3, Álvaro Salazar1, Mauricio Espinoza1, 2, Cecilia Vial4, Analia Cuiza 4, Pablo A. Vial2, 4, 5, and Jerónimo Graf1, 2* 1. Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago 7650567, Chile; [email protected] (R.L.); [email protected] (R.P-A.); [email protected] (Á .S.); [email protected] (M.E); [email protected] (J.G.) 2. Escuela de Medicina. Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile; [email protected] (P.A.V.) 3. Escuela de Kinesiología. Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile 4. Programa Hantavirus, Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago 7590943, Chile; [email protected] (C.V.); [email protected] (A.C.) 5. Departamento de Pediatría, Clínica Alemana de Santiago, Santiago 7650567, Chile Correspondence: [email protected] Abstract Background: Hantavirus cardiopulmonary syndrome (HCPS) has a high lethality. About two-thirds of the severe cases may be rescued by extracorporeal membrane oxygenation (ECMO). However, about half of the patients supported by ECMO suffer major complications. High volume hemofiltration (HVHF) is a depurative extracorporeal support that provides homeostatic balance allowing hemodynamic stabilization in some critically ill patients. Methods: We implemented HVHF prior to ECMO consideration in the last five severe HCPS patients requiring mechanical ventilation and vasoactive drugs admitted to our intensive care unit. -
Hormones and Fluid Balance During Pregnancy, Labor and Post Partum
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ntegrativ Fysiologi, Box 571, %&'()*+ Sweden </ $.% 4--5="6== 4-52366""162"26 ! !!! 623'$ !;; **; > ? ! !!! 623) In memory of my beloved father Ove I lift up my eyes to the hills -- where does my help come from? My help comes from the Lord, the Maker of heaven and earth. He will not let your foot slip -- He who watches over you will not slumber; indeed, He who watches over Israel will neither slumber nor sleep. The Lord watches over you -- the Lord is your shade at your right hand; the sun will not harm you by day, nor the moon by night. The Lord will keep you from all harm He will watch over your life; the Lord will -
Pictures of Central Venous Catheters
Pictures of Central Venous Catheters Below are examples of central venous catheters. This is not an all inclusive list of either type of catheter or type of access device. Tunneled Central Venous Catheters. Tunneled catheters are passed under the skin to a separate exit point. This helps stabilize them making them useful for long term therapy. They can have one or more lumens. Power Hickman® Multi-lumen Hickman® or Groshong® Tunneled Central Broviac® Long-Term Tunneled Central Venous Catheter Dialysis Catheters Venous Catheter © 2013 C. R. Bard, Inc. Used with permission. Bard, are trademarks and/or registered trademarks of C. R. Bard, Inc. Implanted Ports. Inplanted ports are also tunneled under the skin. The port itself is placed under the skin and accessed as needed. When not accessed, they only need an occasional flush but otherwise do not require care. They can be multilumen as well. They are also useful for long term therapy. ` Single lumen PowerPort® Vue Implantable Port Titanium Dome Port Dual lumen SlimPort® Dual-lumen RosenblattTM Implantable Port © 2013 C. R. Bard, Inc. Used with permission. Bard, are trademarks and/or registered trademarks of C. R. Bard, Inc. Non-tunneled Central Venous Catheters. Non-tunneled catheters are used for short term therapy and in emergent situations. MAHURKARTM Elite Dialysis Catheter Image provided courtesy of Covidien. MAHURKAR is a trademark of Sakharam D. Mahurkar, MD. © Covidien. All rights reserved. Peripherally Inserted Central Catheters. A “PICC” is inserted in a large peripheral vein, such as the cephalic or basilic vein, and then advanced until the tip rests in the distal superior vena cava or cavoatrial junction. -
Renal Physiology
Renal Physiology Integrated Control of Na Transport along the Nephron Lawrence G. Palmer* and Ju¨rgen Schnermann† Abstract The kidney filters vast quantities of Na at the glomerulus but excretes a very small fraction of this Na in the final urine. Although almost every nephron segment participates in the reabsorption of Na in the normal kidney, the proximal segments (from the glomerulus to the macula densa) and the distal segments (past the macula densa) play different roles. The proximal tubule and the thick ascending limb of the loop of Henle interact with the filtration apparatus to deliver Na to the distal nephron at a rather constant rate. This involves regulation of both *Department of Physiology and filtration and reabsorption through the processes of glomerulotubular balance and tubuloglomerular feedback. Biophysics, Weill- The more distal segments, including the distal convoluted tubule (DCT), connecting tubule, and collecting Cornell Medical duct, regulate Na reabsorption to match the excretion with dietary intake. The relative amounts of Na reabsorbed College, New York, in the DCT, which mainly reabsorbs NaCl, and by more downstream segments that exchange Na for K are variable, New York; and †Kidney Disease allowing the simultaneous regulation of both Na and K excretion. Branch, National Clin J Am Soc Nephrol 10: 676–687, 2015. doi: 10.2215/CJN.12391213 Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Introduction The precise adaptation of urinary Na excretion to di- Health, Bethesda, Daily Na intake in the United States averages approx- etary Na intake results from regulated processing of an Maryland imately 180 mmol (4.2 g) for men and 150 mmol (3.5 g) ultrafiltrate of circulating plasma by the renal tubular for women (1). -
Kidney Questions
Kidney Questions Maximum Mark Question Mark Awarded 1 12 2 11 3 14 4 12 5 15 6 15 7 16 8 16 9 14 10 14 11 18 Total Mark Page 1 of 44 | WJEC/CBAC 2017 pdfcrowd.com 1. Page 2 of 44 | WJEC/CBAC 2017 pdfcrowd.com Page 3 of 44 | WJEC/CBAC 2017 pdfcrowd.com 2. Roughly 60% of the mass of the body is water and despite wide variation in the quantity of water taken in each day, body water content remains incredibly stable. One hormone responsible for this homeostatic control is antidiuretic hormone (ADH). (a) Describe the mechanisms that are triggered in the mammalian body when water intake is reduced. [6] (b) The graph below shows how the plasma concentration of antidiuretic hormone changes as plasma solute concentration rises. (i) Describe the relationship shown in the graph opposite. Page 4 of 44 | WJEC/CBAC 2017 pdfcrowd.com [2] (ii) Suggest why a person only begins to feel thirsty at a plasma solute concentration of 293 AU. [2] Secretion of antidiuretic hormone is stimulated by decreases in blood pressure and volume. These are conditions sensed by stretch receptors in the heart and large arteries. Severe diarrhoea is one condition which stimulates ADH secretion. (c) Suggest another condition which might stimulate ADH secretion. [1] Page 5 of 44 | WJEC/CBAC 2017 pdfcrowd.com 3. The diagram below shows a single nephron, with its blood supply, from a kidney. (a) (i) Name A, B and C shown on the diagram above. [3] A . B . C . (ii) Use two arrows, clearly labelled, on the nephron above, to show where the following processes take place: [2] I ultrafiltration; Page 6 of 44 | WJEC/CBAC 2017 pdfcrowd.com II selective reabsorption. -
Medicines That Affect Fluid Balance in the Body
the bulk of stools by getting them to retain liquid, which encourages the Medicines that affect fluid bowels to push them out. balance in the body Osmotic laxatives e.g. Lactulose, Macrogol - these soften stools by increasing the amount of water released into the bowels, making them easier to pass. Older people are at higher risk of dehydration due to body changes in the ageing process. The risk of dehydration can be increased further when Stimulant laxatives e.g. Senna, Bisacodyl - these stimulate the bowels elderly patients are prescribed medicines for chronic conditions due to old speeding up bowel movements and so less water is absorbed from the age. stool as it passes through the bowels. Some medicines can affect fluid balance in the body and this may result in more water being lost through the kidneys as urine. Stool softener laxatives e.g. Docusate - These can cause more water to The medicines that can increase risk of dehydration are be reabsorbed from the bowel, making the stools softer. listed below. ANTACIDS Antacids are also known to cause dehydration because of the moisture DIURETICS they require when being absorbed by your body. Drinking plenty of water Diuretics are sometimes called 'water tablets' because they can cause you can reduce the dry mouth, stomach cramps and dry skin that is sometimes to pass more urine than usual. They work on the kidneys by increasing the associated with antacids. amount of salt and water that comes out through the urine. Diuretics are often prescribed for heart failure patients and sometimes for patients with The major side effect of antacids containing magnesium is diarrhoea and high blood pressure. -
Prevalence, Clinical Characteristics, and Predictors of Peripheral Arterial Disease in Hemodialysis Patients: a Cross-Sectional Study Radislav R
Ašćerić et al. BMC Nephrology (2019) 20:281 https://doi.org/10.1186/s12882-019-1468-x RESEARCH ARTICLE Open Access Prevalence, clinical characteristics, and predictors of peripheral arterial disease in hemodialysis patients: a cross-sectional study Radislav R. Ašćerić1* , Nada B. Dimković2,3, Goran Ž. Trajković4, Biljana S. Ristić5, Aleksandar N. Janković2, Petar S. Durić2 and Nenad S. Ilijevski3,6 Abstract Background: Peripheral arterial disease (PAD) is common in patients with end-stage renal disease on hemodialysis, but is frequently underdiagnosed. The risk factors for PAD are well known within the general population, but they differ somewhat in hemodialysis patients. This study aimed to determine the prevalence of PAD and its risk factors in patients on hemodialysis. Methods: This cross-sectional study included 156 hemodialysis patients. Comorbidities and laboratory parameters were analyzed. Following clinical examinations, the ankle-brachial index was measured in all patients. PAD was diagnosed based on the clinical findings, ankle-brachial index < 0.9, and PAD symptoms. Results: PAD was present in 55 of 156 (35.3%; 95% CI, 27.7–42.8%) patients. The patients with PAD were significantly older (67 ± 10 years vs. 62 ± 11 years, p = 0.014), more likely to have diabetes mellitus (p = 0.022), and anemia (p = 0.042), and had significantly lower serum albumin (p = 0.005), total cholesterol (p =0.024),and iron (p = 0.004) levels, higher glucose (p = 0.002) and C-reactive protein (p < 0.001) levels, and lower dialysis adequacies (p = 0.040) than the patients without PAD. Multivariate analysis showed higher C-reactive protein level (odds ratio [OR], 1.03; 95% confidence interval [CI], 1.00–1.06; p = 0.030), vascular access by Hickman catheter (OR, 4.66; 95% CI, 1.03–21.0; p = 0.045), and symptoms of PAD (OR, 5.20; 95% CI, 2.60–10.4; p <0.001) as independent factors associated with PAD in hemodialysis patients. -
Chronic Kidney Disease a Patient’S Guide
Chronic Kidney Disease A Patient’s Guide WHAT IS CHRONIC KIDNEY DISEASE (CKD)? chronic kidney disease, have heart disease or are over 60 years CKD is a preventable and treatable disease. Controlling old, you are at higher risk of CKD and should be screened for diabetes and reducing blood pressure will help you live longer this problem. and feel better. HOW IS CHRONIC KIDNEY DISEASE DIAGNOSED? The kidneys are responsible for removing liquid waste from CKD is diagnosed with (1) a blood test and (2) a urine test. the body. They are basically the body’s water filtration system. The blood test is called a glomerular filtration rate or GFR. If CKD is becoming much more common. Up to 20 million the GFR is above 60, kidney function is adequate and the risks Americans have CKD. If it is not treated early, it causes of major complications are minimal. Although not perfect, the death from heart disease, or the need for an artificial kidney easy way to remember this is that you are SAFE AT 60. machine, called dialysis. The patient may also need a kidney If the urine test shows protein, OR a GFR less than 60, then transplant. Although kidney disease cannot be cured, it can your doctor can give you a medicine called an ACE inhibi- be controlled. With some simple steps, you and your doctor tor or an ARB. These medicines will protect you from having can help to prevent heart attacks. Also, the need for dialysis or your kidney disease worsen. ACE inhibitors always end with transplant can be significantly delayed and perhaps eliminated. -
Renovascular Hypertension
z RENOGRAM INIS-mf —11322 RENOVASCULAR HYPERTENSION G.G. Geyskes STELLINGEN Behorende bij het proefschrift THE RENOGRAM IN RENOVASCULAR HYPERTENSION door G.G. Geyskes \ "n. it f 1 VII Het captopril renogratn kan de diagnostische PTA zoals door Maxwell Paranormale geneeskunde bij patiënten met hypertensie heeft meer bepleit vrijwel vervangen. subjectieve dan objectieve effecten. M.H. Maxwell. A.V. Walu. Hyptritnsion 1914.6:589-392. II VIII Bij dubbelzijdige nierarteriestenose geeft ncfrectomie van een kleine Het lijkt mogelijk de ontwikkeling van diabetische nefropathie af te nier in combinatie met PTA van de contralaterale nier vaak verbetering remmen door medicamenteuze antihypertensieve therapie, speciaal met van de totale nierfunktie. converting enzyme inhibitors. Ill IX Onderdrukking van de PRA is een antihyperteniief mechanisme van Het roken van sigaretten kan een oorzaak van renovaculaire hyperten- betaMokkers. sie zijn. G.G. Geyskts. J. Vos. P. Boer. E.J. Dorhoul Mets. Lmcei 1976:1049-1051. CE. Grimm el al. Nrphron 1986. 44 SI: 96-100. IV Contractie van het extracellulair volume is een antihyperteniief mecha- Het metaiodobenzylguanidine scintigram is een aanwinst bij de diag- nisme van diuretka. nostiek van het feochromocytoom. De opname van deze stof kan ook U.A.M. van Seht». G.G. Geyskti. J.C. Hom. El Dorhoul Mees. therapeutische consequenties hebben. CKn Phorm è Vier 1986. 39:6044, XI Bij veroordeling voor een /.waar misdrijf kan men 't best een levenslange Het clonidine withdrawal syndroom is een vrij sterke contraindicatie tegen het gebruik van dit antihyptttensivum. strul geven die verkort wordt bij verbetering van de mentaliteit. G.G. Geyskts. P. Boer. E.J. -
Home Dialysis
Have you thought about DIALYSIS at There is more than one HOME? way to treat kidney failure. Choosing your treatment is about helping you live your life. GETTING INVOLVED REALLY MATTERS You’ll feel more in charge if you take an active role in the decision. Your kidney team should tell you about all treatment options and the pros and What are the first steps? cons of each. But you make Learn about the different options for treatment of kidney failure. the choice based on your n Talk to the professionals who are treating you. needs, lifestyle, medical n Ask questions: conditions, and current • What treatments are done at home? level of kidney function. In • Am I eligible for home treatments? • How will my choice of treatment affect my order to make this decision, health and lifestyle? you need to learn about all • At this point in my kidney disease, is one choice better than another? the treatments. • Will one treatment better protect my remaining kidney function? Which one? 2 Where can you learn about your options? When you have kidney disease, a team of professionals (your kidney team) will help you understand how your choice will affect your life. Ask questions to be sure what the right option is for you. Discuss the things that are most important to you and any concerns or worries you may have. Visit the National Kidney Foundation website at www.kidney.org for helpful resources. You can also call the NKF Cares patient help line toll-free at 1.855.NKF.CARES (1.855.653.2273) or email [email protected].